分会1——生物技术产业化与科技金融

1、分会1生物技术产业化与科技金融Date 日期Time 时间Agenda 议程Monday星期一June 276月27日Venue地点Co-Chairs主持N220, 2F, Tianjin Meijiang Convention and Exhibition Center天津梅江会展中心2层N220DENG Tianzuo, Associate Counsel, Department of Facilities and Financial Support, The Ministry of Science and Technology of China邓天佐，科技部科研条件与财务司，副巡视员HE

2、 Wei, Director General, Department of Science, Technology and Education, The Ministry of Health of China何维，卫生部科技教育司，司长09:00-09:15Welcome Speech, Leader from Department of Facilities and Financial Support, The Ministry of Science and Technology of China科技部条件财务司领导致欢迎词09:15-09:45Speaker：HE Wei, Directo

3、r General, Department of Science, Technology and Education, The Ministry of Health of ChinaTitle：to be confirmed报告人：何维，卫生部科技教育司，司长报告题目：待定09:45-10:15Speaker：ZHANG Qingkui, General Director, Pharmaceutical and Biological Department, State Intellectual Property Office of the Peoples Republic of China T

4、itle：Strategy for Intellectual Property in Biological Field And Information for Investigation报告人：张清奎，国家知识产权局医药生物审查部，部长报告题目：生物产业知识产权战略及投融资须知10:15-10:30Coffee Break 茶歇10:30-11:00Speaker：MA Hongjian, Deputy Director , China National Center for Biotechnology DevelopmentTitle： The Strategy and Prospect o

5、f the 12th five year for Biotechnology Development in China报告人：马宏建，科技部中国生物技术发展中心，副主任报告题目：“十二五”中国生物技术发展策略与展望11:00-11:30Speaker：LIU Yong, Director, Business Development Bureau, China Development BankTitle：Supporting Bioindustry with Open Finance报告人：刘勇，国家开发银行评审二局，处长/高级工程师报告题目：以开放性金融支持生物产业11:30-12:00Spe

6、aker：WANG Changlin, Director, Institute of Industrial Economy and Technical Economy Academy of Macroeconomic Research, NDRCTitle：The Main Task and The Policy Suggestions of The 12th Five Year for Bioindustry Development in China报告人：王昌林，国家发改委宏观院产业所，所长报告题目：“十二五”时期生物产业发展主要任务与政策措施建议12:00-13:30Lunch 午餐 C

7、o-Chairs主持YANG Shengli, Academician, Shanghai Institutes for Biological Science, Chinese Academy of Sciences杨胜利，中国科学院上海生命科学研究院，院士Hank Nordhoff, Chairman, Gen-ProbeHank Nordhoff, Gen-Probe公司 董事长,13:30-14:00Speaker：Hank Nordhoff, Chairman, Gen-ProbeTitle：The Evolution of Diagnostics: From Body Tempera

8、ture to Biomarkers报告人：Hank Nordhoff，Gen-Probe公司，董事长,报告题目：诊断的发展：从体温到生物标志物14:00-14:30Speaker：Duane Roth, CEO, CONNECT & ROTH Capital, U.S.ATitle：Distributed Partnering报告人：Duane Roth，CONNECT & ROTH Capital 投资公司，首席执行官报告题目：分布式的合作14:30-15:00Speaker：CHEN Yisong, CEO & President, Pallas Global C

9、apital LLCTitle：The Trend in Biotech Industry Investment and Some Thinking in Investment and Policy报告人：陈毅松，德通寰球资本有限公司，首席执行官/总裁报告题目：生物产业的投资趋势和一些投资及政策思考15:00-15:30Speaker：Ting Pau Oei，Partner，L Capital PartnersTitle：The Role of Venture Capital in Financing Biotechnology报告人：Ting Pau Oei，L Capital Partn

10、ers投资公司，合伙人报告题目：风险投资在生物技术融资中的作用15:30-15:45Coffee Break 茶歇15:45-16:15Speaker：JIANG Feng, President, China Innovation Strategic Alliance of Medical DevicesTitle：Reflections of The Science and Technology Finance in The Medical Device Industry报告人：姜峰，科技部医疗器械产业技术创新联盟，理事长报告题目：医疗器械产业科技金融的几点思考16:15-16:45Spea

11、ker：DAI Xiaochang, Managing Partner, Shanghai HPI LLPTitle： Angel Investors to GEMVenture Capital Boost Bioindustry报告人：戴晓畅，上海衡康投资管理合伙企业，执行合伙人报告题目：天使投资到创业板风险资本助推生物产业16:45-17:15Speaker：ZHANG Shiyuan, Chief Researcher, Southwest Securities Co., Ltd.Title：Transformation Promotes Bioindustry Development报

12、告人：张仕元，西南证券有限责任公司，首席研究员报告题目：变革推动生物产业进入繁荣期18:30-19:30Dinner 晚餐分会2前沿生物技术分会日期（Date）时间表（Time Slot）议程（Agenda）2011年6月27日, 星期一(June 27th,， 2011. Monday)Venue地点Co-Chairs主持N211, 2F, Tianjin Meijiang Convention and Exhibition Center天津梅江会展中心2层N211RAO Zihe, Tsinghua University/Nankai University/Institute of Bio

13、physics,CAS 饶子和院士，清华大学/南开大学/中科院生物物理所Raymond C. Stevens, Departments of Molecular Biology and Chemistry, The Scripps Research Institute, La Jolla, California, USARaymond C. Stevens教授，美国 Scripps 研究所09:00-09:30Speaker：Professor George F Gao, Institute of Microbiology, Chinese Academy of SciencesTitle：2

14、009 Pandemic influenza virus: what special for its HA and NA报告人：高福，中国科学院微生物研究所，教授报告题目：2009甲型H1N1流感病毒囊膜蛋白HA和NA的结构特异性09:30-10:00Speaker：Professor Ian Jones, School of Biological Sciences, University of Reading, United KingdomTitle：Next generation vaccines produced in insect cells报告人：Ian Jones ，英国雷丁大学生

15、命科学学院，教授 报告题目：利用昆虫细胞生产的新一代疫苗10:00-10:30Speaker：Professor ZHOU Qi, Institute of Zoology, Chinese Academy of SciencesTitle：Progress and potential application of Stem Cell Research and Regenerative Medicine报告人：周琪，中国科学院动物研究所，教授报告题目：干细胞及再生医学研究进展及潜在应用10:30-10:45茶歇（Coffee Break）10:45-11:15Speaker：Professor

16、 Thomas Kay, St. Vincents Institute, AustraliaTitle：New Technologies to Treat Type 1 Diabetes报告人： Thomas Kay ，澳大利亚St. Vincents 研究所，教授报告题目：治疗1型糖尿病的新技术11:15-11:45Speaker：Raymond C. Stevens, Departments of Molecular Biology and Chemistry, The Scripps Research Institute, La Jolla, California, USATitle：N

17、ew Drug Discovery Paradigms for G-protein Coupled Receptors报告人： Raymond C. Stevens，美国 Scripps 研究所，教授报告题目： G蛋白偶联受体的新型药物开发模式11:45-12:15Speaker：Professor WANG XiaoningTitle：Talent, Team and the R&D报告人：王小宁，教授报告题目：人才、团队、与产业发展12:15-13:30午餐（Lunch）Co-Chairs主持Professor ZHANG Zhuohua , Central south Unive

18、rsity张灼华，中南大学，教授14:00-14:30Speaker：Professor HE Lin, The Bio-X Center, Shanghai Jiao Tong UniversityTitle：The Effects of Food and Drug on Earlier Stage Prevention from Diseases报告人：贺林，上海交通大学Bio-X中心/复旦大学/上海生科院营养科学研究所，院士报告题目：食品与药品在疾病预防关口前移中的作用14:30-15:00Speaker：Professor Neil Isaacs, University of Glas

19、gow, UKTitle：Learning from Nature Using Molecular Structures as Design Templates报告人：Neil Isaacs，英国格拉斯哥大学，教授报告题目：来自自然的启发: 利用分子结构作为设计模板15:00-15:30Speaker：Professor Barbara Howlett, School of Botany, the University of Melbourne, Vic 3010Title：Exploiting the genome sequence of a fungal pathogen to minim

20、ize plant disease报告人：Barbara Howlett，墨尔本大学植物学院，教授报告题目：通过探索真菌病原体的基因组序列来减少植物病虫害15:30-15:45茶歇 （Coffee Break）15:45-16:15Speaker：Professor ZHANG Hong,National Institute of Biological SciencesTitle：Autophagy in the pathogenesis of disease报告人：张宏，北京生命科学研究所，教授报告题目：细胞自噬和疾病的发生16:15-16:45Speaker：Professor Peter

21、 Colman, The Walter and Eliza Hall Institute of Medical ResearchTitle：Neuraminidase inhibitors for treatment and prophylaxis of influenza: discovery and characteristics报告人：Peter Colman，澳大利亚The Walter and Eliza Hall 医学研究所，教授报告题目：用于治疗和预防流感的神经氨酸苷酶抑制剂的发现和特性16:45-17:15Speaker：Professor ZHANG Zhuohua, Cen

22、tral south UniversityTitle：Connexin-31 Diseases: from Gene to Treatment报告人：张灼华，中南大学，教授 报告题目： Connexin-31疾病：从基因到治疗17:15-17:45Speaker：Professor Geoffrey Howlett, Department of Biochemistry and Molecular Biology and Bio21 Molecular Science and Biotechnology Institute, University of MelbourneTitle：Lipid

23、 Modulators of Amyloid Fibril Formation in Disease报告人：Geoffrey Howlett ，墨尔本大学，教授报告题目：疾病中类淀粉样纤维形成的脂类调解因子17:45-18:15Speaker：Professor Bob Sim, Oxford UniversityTitle：Advances in monitoring function and pharmacological control of the innate immune system.报告人：Bob Sim，英国牛津大学，教授报告题目：先天性免疫系统中监控机制及药物控制的研究新进

24、展18:30-19:30晚餐 （Dinner）分会3农业生物技术分会Date 日期Time 时间Agenda 议程Monday星期一June 276月27日Venue地点Co-Chairs主持N217, 2F, Tianjin Meijiang Convention and Exhibition Center天津梅江会展中心2层N217LI Ning, Academician, China Agricultural UniversityLaible Goetz,Professor,Agresearch李宁，中国农业大学，院士Laible Goetz，新西兰Ag研究所,教授09:00-09:25

25、Speaker：Laible Goetz,Professor,AgresearchTitle：Cell-mediated transgenesis of livestock for biopharming and improved dairy products.报告人：Laible Goetz，新西兰Ag研究所，教授报告题目：利用细胞介导的转基因家畜在生物医药和奶产品改良方面的应用。09:25-09:50Speaker：ZHAO Yaofeng ,Professor,China Agricultural UniversityTitle：Multiplication of Human lacto

26、ferrin transgenic cattle and safety evaluation of the resultant milk报告人：赵要风，中国农业大学，教授报告题目：转人乳铁蛋白基因奶牛的规模化生产09:50-10:10Coffee Break 茶歇10:10-10:35Speaker：LV Yuping ,Director,Department of Biotechnology,Beijing DBN Technology GroupTitle：Research and Development in agrobiotechnology of China报告人：吕玉平，大北农生物

27、技术部，主任报告题目：智创中国农业生物技术研发10:35-11:00Speaker：Forsberg Cecil,Professor,University of GuelphTitle：A transgenic phytase pig ready for commercialization that provides a stable platform for the addition of other beneficial traits报告人：Forsberg Cecil，加拿大圭尔夫大学，教授报告题目：可商业化植酸酶转基因猪的制备11:00-11:25Speaker：LAI Liangxu

28、e , Professor, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of SciencesTitle：Genetic Modification of Pigs for Human disease.报告人：赖良学，中科院广州生物医药与健康研究院，研究员报告题目：关于人类疾病猪的基因修饰11:25-11:50Speaker：ZHANG Zehua , Professor, The institute of plant protection, Chinese Academy of Agricultural Sc

29、iencesTitle：Opportunities and Challenges of Bio-pesticide Development in China报告人：张泽华，中国农科院植保所，研究员报告题目：中国生物农药发展机遇与挑战12:00-13:30Lunch 午餐Co-Chairs主持LI Ning , Academician, China Agricultural UniversityLaible Goetz,Professor,Agresearch李宁，中国农业大学，院士Laible Goetz，新西兰Ag研究所,教授14:00-14:25Speaker：Etches Robert,

30、 Chief Executive, Crystal BioscienceTitle：Inserting modifications into the chicken genome报告人：Etches Robert, Crystal Bioscience, 公司总经理报告题目：鸡基因组的基因插入改造14:25-14:50Speaker：LAI Jinsheng ,Professor, China Agricultural UniversityTitle：Maize genome research and molecular breeding报告人：赖锦盛，中国农业大学，教授报告题目：玉米基因组学

31、研究与分子设计育种14:50-15:15Speaker：John McLean, General Manager of Monsanto Research Center, ChinaTitle：Monsanto and Our Approach to Research & Development报告人：麦科林，总经理，孟山都生物技术研究中心（中国）报告题目：孟山都公司研发进展概况15:15-15:35Coffee Break 茶歇15:35-16:00Speaker：YU Jun ,Professor and Vice President,Beijing Institute of Ge

32、nomics of Chinese Academy of SciencesTitle：The personalized Era of Human Health and Disease Research 报告人：于军，中国科学院北京基因组研究所，研究员，副所长报告题目：医学、健康与疾病研究的个体化时代16:00-16:25Speaker：XING Yongzhong ,Professor,Huazhong Agricultural UniversityTitle：Functional genomics research and genetic improvement in rice报告人：邢永忠

33、，华中农业大学，教授报告题目：水稻功能基因组研究和遗传改良16:25-16:50Speaker：CHEN Hualan ,Professor,Harbin Veterinary Research Institute ,Chinese Academy of AgriculturalTitle：Development and application of H5N1 avian influenza vaccines报告人：陈化兰，中国农科院哈尔滨兽医研究所，研究员报告题目：H5N1禽流感疫苗的研究及应用18:30-19:30Dinner 晚餐 分会4医药生物技术分会Date 日期Time 时间Age

34、nda 议程Monday星期一June 276月27日Venue地点Co-Chairs主持N215, 2F, Tianjin Meijiang Convention and Exhibition Center天津梅江会展中心2层N215CHEN Zhinan , The Fouth Military Medical University ,Academician 陈志南，第四军医大学，院士 09:00-09:25Speaker ：Frank Jiang, Sanofi-Aventis,Dr.Title：Translational Medicine: a critical approach in

35、 speeding up new drug RD报告人：Frank Jiang，赛诺菲安万特，博士报告题目：转化医学：加快新药研发的关键途径09:25-09:50Speaker：WEI Yuquan, Sichuan University, AcademicianTitle：Advances In Gene Therapy报告人：魏于全，四川大学，院士报告题目：基因治疗进展09:50-10:15Speaker：WANG Junzhi ,National Institute for the Control of Pharmaceutical & Biological Products,

36、Vice PresidentTitle：Biotechnology drugs and translational medicine报告人：王军志，中国食品药品检定研究院，副院长报告题目：生物技术药物与转化医学10:15-10:30Coffee Break 茶歇10:30-10:55Speaker：CHEN Huipeng, Institute of Biotechnology, Academy of Military Medical Sciences of Chinese PLA, DirectorTitle：The Secondary Development of Protein Drug

37、s报告人：陈惠鹏，军事医学科学院生物工程研究所，所长报告题目：蛋白质药物的二次开发10:55-11:20Speaker：JIN Li, Fudan University, Vice PresidentTitle：Large cohort studies in China:challenges and opportunities报告人：金力，复旦大学，副校长报告题目：中国的大型队列研究：机遇和挑战11:20-11:45Speaker：Lily Yao, University of Birmingham, Dr.Title：Economic Evaluation of a regenerative

38、 medicine in the treatment of cartilage defects of the knee报告人：Lily Yao，伯明翰大学，高级研究员报告题目：关于治疗膝关节软骨缺损再生医学的经济学评价12:00-13:30Lunch 午餐Co-Chairs主持Frank Jiang, Sanofi-Aventis,Dr.Frank Jiang，赛诺菲安万特，博士13:30-13:55Speaker：CHEN Zhinan The Fouth Military Medical University,AcademicianTitle：Progress of Translation

39、al Medicine & Antibody Based Biopharmaceuticals in China报告人：陈志南，第四军医大学，院士报告题目：基于抗体的生物制药产业与转化医学进展13:55-14:20Speaker：ZHENG Qiang , Peking University, ProfessorTitle：Lifecycle Quality Management of Biologics报告人：郑强，北京大学，教授报告题目：生物制剂全周期质量管理14:20-14:45Speaker：LIANG Zicai , Peking University, ProfessorT

40、itle：siRNA technology and drug development in China报告人：梁子才，北京大学，教授报告题目：勿以善“小”而不为：中国小核酸技术产业创新体系建设14:45-15:10Speaker：Bradley Marchant, Sanofi-AventisTitle：Unique opportunities for drug development in China报告人：Bradley Marchant，赛诺菲安万特，博士报告题目：药物研发在中国的发展良机15:10-15:35Speaker：SHI Jinhai, Tianjin Internation

41、al Joint Academy of Biotechnology & Medicine, ProfessorTitle：The Safety Assessment of Monoclonal Antibody Drug报告人：史晋海，天津国际生物医药联合研究院，副院长报告题目：单克隆抗体药物的安全评估15:35-15:50Coffee Break 茶歇15:50-16:15Speaker：XIA Ninshao, Xiamen University, ProfessorTitle：Current situation and trend of in vitro diagnostic p

42、roducts报告人：夏宁邵，厦门大学，教授报告题目：体外诊断产品的现状与发展16:15-16:40Speaker：ZOU Quanming , The Third Military Medical University, ProfessorTitle：Progress on New Vaccine报告人：邹全明，第三军医大学，研究员报告题目：新型疫苗研究进展16:40-17:05 Speaker：Mr. Sijmen de Vries, Pharming Group N.V.Leiden, the Netherlands,CEOTitle：Technology platform f

43、or transgenic therapeutical proteins报告人：Mr. Sijmen de Vries，Pharming Group N.V. ，首席执行官报告题目：转基因治疗型蛋白技术平台17:05-17:30Speaker：LIU Wei, Shanghai 9th People's Hospital Affiliated to Shanghai JiaoTong University Medical School, ProfessorTitle：Tissue engineering reseach and potential product development

44、报告人：刘伟，上海交通大学医学院附属第九人民医院，教授报告题目：组织工程研究和相关产品开发18:30-19:30Dinner 晚餐 分会5化学药分会Date 日期Time 时间Agenda 议程Monday星期一June 276月27日Venue地点Co-Chairs主持N213, 2F, Tianjin Meijiang Convention and Exhibition Center天津梅江会展中心2层N213DING Jian , Academician, General Director, Shanghai Institute of Materia Medica, CASLI En,

45、General Manager, China Novartis Institutes for BioMedical Research Co., Ltd.丁健，中国科学院上海药物研究所所长，院士李恩，诺华（中国）生物医学研究有限公司总经理08:30-09:00Speaker：LI En , General Manager, China Novartis Institutes for BioMedical Research Co., Ltd.Title：Science driven drug discovery: from target to therapy报告人：李恩，诺华（中国）生物医学研究有

46、限公司总经理报告题目：科技促进药物发现:从靶标到治疗09:00-09:30Speaker：ZHU Weiliang, Professor, Head of DDDC, Shanghai Institute of Materia Medica, CASTitle：Target Identification and Lead Discovery by Using Computational Methods报告人：朱维良，中国科学院上海药物研究所药物发现与设计中心主任，研究员报告题目：通过计算方法的靶标确证和先导化合物发现09:30-10:00Speaker：LIU Changxiao, Acade

47、mician, Tianjin Institute of Pharmaceutical ResearchTitle：The role of Pharmacokinetics in translation research for research and development of newdrugs报告人：刘昌孝，天津药物研究院，院士报告题目：药代动力学在新药研发转换研究中的作用10:00-10:15Coffee Break 茶歇10:15-10:45Speaker：HE Wei , President & CEO, WMH BiopharmaTitle：Small Molecule

48、 Drug Innovation & Development报告人：何伟，美国微美华药总裁兼首席执行官报告题目：小分子药物开发和自主创新10:45-11:15Speaker：Peng Cho TANG, Chief Scientific Consultant, HEC Pharm Co., Ltd.Title：INDs: US to China to US Formula for Me-better Drug Discovery in China报告人：邓炳初，广东东阳光药业有限公司首席原创新药顾问报告题目：新药临床研究申请:在中国模仿创新药物开发的从美国到中国再到美国方程式11:15

49、-11:45Speaker：HAO Xiaojiang , Professor, Kunming Institute of Botany, CASTitle：Approach on the Discovery of Natural Leads from Plants报告人：郝小江，中国科学院昆明植物研究所，研究员报告题目：植物中天然先导化合物的发现12:00-13:30Lunch 午餐Co-Chairs主持DING Jian , Academician, General Director, Shanghai Institute of Materia Medica, CASLI En, Gene

50、ral Manager, China Novartis Institutes for BioMedical Research Co., Ltd.丁健，中国科学院上海药物研究所所长，院士李恩，诺华（中国）生物医学研究有限公司总经理14:00-14:30Speaker：ZHAO Shuhai , Head of Virology Chemistry, Roche R&D Center (China) LtdTitle：De-risking the potential of cardiovascular toxicity by rational design报告人：赵树海，罗氏研发（中国）有

51、限公司病毒药物化学部主管报告题目：通过新药设计来减少心血管系统的副作用14:30-15:00Speaker：JIANG Jiandong , Professor, General Director, Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical CollegeTitle：New strategies to overcome drug-resistance in treating HBV infection报告人：蒋建东，中国医学科学院药物研究所所长，研究员报

52、告题目：克服HBV病毒耐药的新策略15:00-15:30Speaker：YUE Guohua , President & CEO, Antagen Pharmaceuticals, Inc.Title：Passing or Bypassing Blood Brain Barrie报告人：岳国华，美国安塔臻制药有限公司，董事长兼首席执行官报告题目：越过血脑屏障15:30-15:45Coffee Break 茶歇15:45-16:15Speaker：ZHANG Dan , President, Fountain Medical Development Ltd.Title：From benc

53、h to bed报告人：张丹，方恩（天津）医药发展有限公司董事长报告题目：从实验室研究到临床研究16:15-16:45Speaker：LV Qiang , VP of Biology, Wuxi ApptecTitle：WuXiApptec: Drug Development Platform for the Next Decade报告人：吕强，药明康德新药开发有限公司生物研发副总裁报告题目：药明康德:未来的新药研发平台16:45-17:15Speaker：HE Yun , Sr. VP and CSO, BioDuro/PPDTitle：Integrated Drug Discovery S

54、ervices in China - Opportunities and Challenges报告人：贺耘，保诺科技（北京）有限公司，高级副总裁兼首席科学官报告题目：中国一体化的药物发现服务机遇和挑战17:15-17:45Speaker：WANG Ying , Vice President of Drug Safety, Hua Medicine Ltd.Title：Role and Responsibility of Non-Clinical Safety Evaluation in New Drug Development报告人：王英，华医药有限公司，药物安全与注册部副总裁报告题目：非临床

55、安全性评价在新药开发过程中的作用与责任18:30-19:30Dinner 晚餐 分会6中医药分会Date 日期Time 时间Agenda 议程Monday星期一June 276月27日Venue地点Co-Chairs主持N219, 2F, Tianjin Meijiang Convention and Exhibition Center天津梅江会展中心2层N219ZHANG Boli,Academician,China Academy of Traditional Chinese Medicine/Tianjin University of Traditional Chinese Medici

56、ne张伯礼，中国中医科学院、天津中医药大学，院士08:30-08:45Speaker：ZHANG Boli, Academician,China Academy of Traditional Chinese Medicine/Tianjin University of Traditional Chinese MedicineTitle：The Purport for Traditional Chinese Medicine Development of 2011 International Conference for Bioeconomy.报告人：张伯礼，中国中医科学院、天津中医药大学，院士报告题目：2011国际生物经济大会中医药分会主旨发言08:45-09:00Speaker：WU Yiling, Academician, Shijiazhuang Yiling Pharmaceutical Co., Ltd